Industry

Latest Data and Live Broadcast Show Promise of Vascular Dynamics’ MobiusHD Device IRVINE, Calif.–(BUSINESS WIRE)–Vascular Dynamics, Inc. (VDI), a privately held medical device company focused on developing game-changing endovascular device-based solutions for patients suffering from heart failure, announced that the endovascular baroreflex amplification (EVBA) procedure using its MobiusHD device to treat patients with heart failure … [Read more…]

ST. LOUIS–(BUSINESS WIRE)–Global rigid container and life sciences packaging distributor, Novvia Group (“Novvia”), has acquired Duval Container Company (“Duval Container”), a distributor of plastic, metal, fiber, and glass packaging products. Financial terms of the private transaction were not disclosed. Novvia is backed by Kelso & Company (“Kelso”). Headquartered in Jacksonville, FL, Duval Container is a … [Read more…]

Risk-based, 2-year Certification Validates Company’s Commitment to Meeting Key Regulations and Protecting Sensitive Information ANN ARBOR, Mich.–(BUSINESS WIRE)–#AIforDental—NovoDynamics, Inc., the proven artificial intelligence (AI) solutions provider, today announced that its AI-driven insurance claim support system NovoHealth Dental, running in numerous cloud and on-premise environments, has earned Certified status for information security by HITRUST. HITRUST Risk-based, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course” conference has been added to ResearchAndMarkets.com’s offering. This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development, or need to provide the regulators with specific usability data for … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Celiac Disease – Epidemiology Forecast to 2032” report has been added to ResearchAndMarkets.com’s offering. This “Celiac Disease – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Celiac Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “USA Antibody Drug Conjugates Market – Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. By target, the USA antibody drug conjugates market has been segmented into CD 30, CD 22, and HER 2. CD 30 is expected to hold a notable share of the market during the forecasted period. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Colonoscopy Devices – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Colonoscopy Devices Market to Reach $1.8 Billion by 2026 Amid the COVID-19 crisis, the global market for Colonoscopy Devices estimated at US$1.6 Billion in the year 2022, is projected to reach a revised size of US$1.8 Billion … [Read more…]

RONKONKOMA, N.Y.–(BUSINESS WIRE)–Qosina, a global supplier of OEM single-use components to the medical and biopharmaceutical industries, is pleased to introduce the AseptiQuik® STC connectors to its line of Steam-Thru® connectors. The AseptiQuik® STC Series integrate the AseptiQuik® sterile connector and the Steam-Thru®II Steam-in-Place connector, giving manufacturers flexibility between hybrid stainless steel and single-use processing equipment. … [Read more…]

SAN FRANCISCO–(BUSINESS WIRE)–#AI—Viz.ai, the leading AI-powered disease detection and intelligent care coordination platform, announced today it is partnering with Hyperfine, Inc. (Nasdaq: HYPR), creator of the first FDA-cleared point-of-care magnetic resonance imaging (MRI) device, Swoop®. Together, they will bring MRI to the patient’s bedside and deliver valuable insights to the clinician’s fingertips for timely decision … [Read more…]

Amytrx expanding their bioactive peptide platform AMTX-100 has unique specificity to target leukocytes involved in the overactive immune response AmbioPharm providing peptide manufacturing support for Amytrx Amytrx looking to expand partnerships to advance new or complementary therapies NASHVILLE, Tenn. & NORTH AUGUSTA, S.C.–(BUSINESS WIRE)–#antiinflammatory—Amytrx Therapeutics, a mission-driven biopharmaceutical company dedicated to commercializing transformative and cutting-edge … [Read more…]